CLINICAL ROLE -
Drug Diversion and Abuse: A Deadly Mixture
Read More
Prescription Monitoring Programs, 2014
Drug Diversion and Abuse: DEA Allows Rx Returns
DEA Rule Allows Relaxed Take-Back of Rx Medications
Hydrocodone Combination Products: Moving from CIII to CII
The Drug Enforcement Administration recently announced that all hydrocodone products will have a Cll status effective October 6, 2014.
Rescheduling Marijuana
The DEA has asked the FDA to consider rescheduling marijuana.
Benzodiazepine Abuse on the Rise
The steady illicit use of benzodiazepines, especially alprazolam, should not be ignored.
The Heroin Epidemic and Abuse-Deterrent Formulations
It's no surprise that heroin, readily available and at prices far lower than those of pharmaceuticals, is the abuser's current drug of choice.
Drug Diversion and Abuse: The FDA and Politicians: The Zohydro ER Debate
Even though the FDA approved Zohydro ER, politicians have either banned the drug on the state level through executive order or introduced legislation to do so.
Zohydro ER: A New Chronic Pain Product Launch
There has been quite a bit of chatter among law enforcement authorities and health professionals about the launch of this extended-release hydrocodone product.
Drug Diversion and Abuse: The Future of Rx Abuse
Our columnist sees a bright future for abuse-resistant formulations.
Drug Diversion and Abuse: Generation Rx Initiative: The OSU Project
Cmdr Burke connects with the OSU College of Pharmacy's program for reducing prescription drug abuse.
Drug Diversion and Abuse: Rescheduling of Hydrocodone
The FDA recently cleared the way for giving hydrocodone combination products a CII status, so pharmacists should be prepared for the consequences of this potential change.
Drug Diversion and Abuse: "Medical" Marijuana Revisited
The legalization of medical marijuana by many states continues to be a hot topic.
Drug Diversion and Abuse: Staring Down the Barrel
The author highlights the book Staring Down the Barrel, which addresses the growing concerns and problems facing everyday pharmacists as they are confronted by prescription drug diverters and armed robbers.
Rx Abuse Prevention for Children: A New Pilot Program
NADDI has announced a new program to educate the very young about drug safety and abuse.
Drug Diversion and Abuse: Ordering Rx Drugs from Outside the United States
Thousands of criminal Internet pharmacies dispense millions of dosage units of pharmaceuticals.
Drug Diversion and Abuse: Tactics for the War on Drugs
The author presents 3 important strategies.
Drug Diversion and Abuse: Senseless Acts of Violence in the Pharmacy Again
Measures can be taken to reduce and improve the outcome of crime in the pharmacy.
Drug Diversion and Abuse: OxyContin and the FDA
Drug task force data reveal the abuse-deterrent reformulation of OxyContin to be an overwhelming success.
Drug Diversion and Abuse: Anabolic Steroids: The China Connection
China has become a major supplier of anabolic steroids and counterfeit look-alikes to US traffickers.
Drug Diversion and Abuse: Rx Boxes 2013
Prescription drug take back programs keep dangerous medications out of the wrong hands.
Drug Diversion and Abuse: VA Agrees to PMP Database Dump
State prescription-monitoring programs will now have access to a wealth of VA hospital data.
Drug Diversion and Abuse: NYC Fights Rx Abuse
A 2-part initiative to deter painkiller abuse and pharmacy robberies is underway in New York City.
Update on Abuse-Resistant Formulations
Should abuse-deterring features be required for approval of new opioids?
Rx Abuse and Diversion 2013
Collaboration will be critical in the upcoming year.
Drug Diversion and Abuse: Finding Balance in the Rx World
In the crackdown on abuse of painkillers, legitimate patients can end up facing undue suspicion.
Drug Diversion and Abuse: Health Facility Diversion in the News
Health care professionals are sometimes a part of the drug diversion and abuse problem.
Drug Diversion and Abuse: Nasal Naloxone and Law Enforcement
Prevention methods, although difficult to measure, have a positive impact on curbing substance abuse among the youth of this country.
Drug Diversion and Abuse: Hydrocodone: CII or CIII?
Despite the rampant abuse of hydrocodone/acetaminophen, the debate over its classification continues.